Serind Pharma Private Limited
About Serind Pharma Private Limited
Data last updated:
Serind Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC116257.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.68 Cr. It is led by directors Sandhya Nandiraju and Udayalakshmi Suresh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.3 – 6 – V/77 Plot No.77 Vivekanandanagar, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.15 Lakh. For the same year it recorded a net loss of ₹37.34 Lakh and EBITDA of -₹39.55 Lakh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Serind Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No.3 – 6 – V/77 Plot No.77 Vivekanandanagar, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Serind Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Serind Pharma Private Limited
FY 2025 filings availableSerind Pharma Private Limited reported revenue of ₹3.15 Lakh for FY 2020.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹3.15 Lakh | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹39.55 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹37.34 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Serind Pharma Private Limited, buy the company report.
Board of directors of Serind Pharma Private Limited
Serind Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya Nandiraju | Director | 30 Mar 2017 | 9 Years 6 Months | Current |
| Udayalakshmi Suresh Also directs: Atisa Life Sciences Private Limited | Director | 16 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Serind Pharma Private Limited is audited by M V NARAYANA REDDY & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M V NARAYANA REDDY & CO | FY 2019 | 002370S |
Shareholding
The shareholding of Serind Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Serind Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Serind Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Serind Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Serind Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Serind Pharma Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Satyanarayana Murthy Nandiraju ceased to be Director on 21 Jul 2025.
Frequently asked questions
Serind Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2017 (9+ years old) and is registered under CIN U74999TG2017PTC116257.
Serind Pharma has 2 current directors:
- Sandhya Nandiraju - Director
- Udayalakshmi Suresh - Director
The latest financial statements of Serind Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Serind Pharma is U74999TG2017PTC116257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serind Pharma was incorporated on 30 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Satyanarayana Murthy Nandiraju ceased to be Director on 21 Jul 2025. Udayalakshmi Suresh was appointed as Director on 16 Jul 2025. Sandhya Nandiraju was appointed as Director on 30 Mar 2017.
The registered office of Serind Pharma is at H No.3 – 6 – V77 Plot No.77 Vivekanandanagar, Hyderabad, Telangana, India – 500072.
Serind Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Serind Pharma is compliant as of 01 August 2026. The company is actively filing with the Registrar of Companies.
Serind Pharma can be reached at its registered office: H No.3 – 6 – V77 Plot No.77 Vivekanandanagar, Hyderabad, Telangana, India – 500072.